SUNNYVALE, Calif. and BIRMINGHAM, Ala., June 27, 2022 /PRNewswire/ -- Cepheid and BioGX today announced a collaboration between the two companies to deliver a PCR test for Monkeypox that will run on ...
Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE, Calif., ...
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced ResistancePlus® MG FleXible for the Cepheid GeneXpert® System, detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) ...
Though the global number of recorded monkeypox cases continues to climb—passing 4,100 last week, according to the Centers for Disease Control and Prevention (CDC)—many researchers and epidemiologists ...
In Mexico, Cepheid has received registration from the Secretary of Health for its GeneXpert System and Xpert (TM) MRSA, Xpert GBS and Xpert EV tests. The products will be distributed exclusively ...
SpeeDx to bring first sample-to-answer Mycoplasma genitalium and macrolide resistance test to Europe SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced the European launch of ResistancePlus® MG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback